Platelet Aggregation Inhibitors

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

Correct Timing of Head Imaging in Trauma

GM03 - Platelet RNA Signatures of Aspirin

Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)

Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention

Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia

Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)

The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients

Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings

Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction

The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients

ACCEL-LOADING-ACS Study

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)